Lv31
288 积分 2023-10-07 加入
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
2个月前
已完结
重组英夫利西单抗的关键技术研发及应用
2个月前
已完结
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
4个月前
已完结
Hepatosplenic Hodgkin lymphoma without lymphadenopathy following reversible methotrexate-associated lymphoproliferative disorder
4个月前
已完结
Biomarker Guided Infliximab Therapy for Immune Checkpoint Inhibitor-induced Acute Interstitial Nephritis
5个月前
已完结
Comparative Safety of Janus Kinase inhibitors vs. Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases
5个月前
已完结
N-糖基化对TNFR-Fc融合蛋白结构稳定性和生物活性的影响
6个月前
已关闭
Applications of proteomic methods for CHO host cell protein characterization in biopharmaceutical manufacturing
6个月前
已完结
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis
6个月前
已完结
Cell culture media for recombinant protein expression in Chinese hamster ovary (CHO) cells: History, key components, and optimization strategies
6个月前
已完结
皖公网安备34019202002308
